Monimax® - The Reliable Solution

reading time
Product | 30.07.2020

One of the potential problems when using anticoccidials is that the animals do not consume the correct amount of the active compound.

Since anticoccidials are mixed with the feed, segregation is a potential risk with the result that one bird might receive too high a concentration and another too low. When birds consume too low a concentration of anticoccidials, this will lead to insufficient coccidiosis control. And when the concentration is too high, it might lead to intoxication or residues. The risk is intensified with combination products where the correct ratio between the different active compounds is very important. The potential for segregation is greatly influenced by the product formulation. 

Monimax® is produced by microgranulation which results in the active ingredients (nicarbazin and monensin) and the carriers being inseparably combined in the granules, guaranteeing uniform mixing and dosing in the feed and reducing the risk of cross-contamintion in feed mills. 

Figure 1. One granule of the microgranulated product combines the active compounds (monensin graphically represented in red, nicarbazin in brown) and the carrier (white)

The potential for segregation can be demonstrated by a sieving test, showing the particle size distribution of a product.

In this sieving test, a sample of Monimax® and a sample of another EU registered combination product (nicarbazin/narasin) were put through a range of sieves with different mesh sizes, resulting in separation into different fractions based on particle size. In each separated fraction, the concentration of the active components was determined.

In Monimax®, the targeted concentration is 80 mg/g for both nicarbazin and monensin.

For the nicarbazin/narasin combination, the targeted concentration is 80 mg/g for both active compounds.

Figure 2. Content of active compounds in various feed particle size fractions for Monimax®

From the sieving test, it can be concluded that Monimax® shows a particle size distribution optimized for the prevention of segregation in compound feed (Figure 2). The dust fraction (<100 μm) is negligible. Furthermore, in each fraction, the nicarbazin and monensin content is very close to the targeted content, which proves the uniform distribution of both active compounds in the product. Monimax® ensures precise delivery of nicarbazin and monensin leading to superior product performance and a high confidence factor in the feed mill. 

Figure 3. Content of active compounds in various feed particle size fractions for an EU registered combination product (nicarbazin / narasin)

By contrast, the results of the nicarbazin/narasin combination product sieving test (Figure 3) show a large spread of nicarbazin and narasin content in the different fractions. In the most important fractions (largest percentage of total i.e. fractions 250 - 315 μm, 315 - 500μm and 500 - 710 μm), the narasin concentrations range between 75% and 150% of the targeted concentration and the nicarbazin concentrations between 6.25% and 170% of the targeted concentration. This clearly complicates the uniform production of feed with equal distribution of each active compound. 

Moreover, in the dust fraction (<100 μm), the concentration of narasin is 143% of the targeted concentration. As the dust fraction can have a detrimental impact on the risk for cross-contamination in the feed mill, it is clear that this poses a risk. Narasin is extremely toxic for turkeys, so feed mills producing feed for broilers and turkeys should take care.


The microgranulation technique used to produce Monimax® ensures that both active compounds are present in every granule. This is in contrast to simple mixing of different active compounds in the product as used in other combination products available commercially. The microgranulated formulation of Monimax® guarantees uniform distribution of both active compounds in the product, allowing optimal dosing of both monensin and nicarbazin to the birds. In addition, Monimax® is registered for use in turkeys and rearing pullets. The microgranulation quality and broad poultry species registration makes Monimax® the combination product of choice for feed mills. 



global presence

Local support from a global company

Huvepharma® has a distribution network which covers more than 90 countries in 6 continents. Find your nearest Huvepharma® representative today.
Find your local contact
about us


Huvepharma® is a fast-growing, global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health and nutrition products.
more about us

Change country

The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.

To view all products and services, select Global from the dropdown menu or click .




North America


South America

Change language

Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.


United States

Click here to visit the local website or close this popup to stay on the global website.

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now